Showing 811 - 820 of 883 for "King & Wood Mallesons (China)" with applied filters
01 September 2017 by
New Balance has won in a trade mark infringement dispute in a first instance decision from the Suzhou Intermediate People’s Court. The court ordered the defendants to pay damages and legal costs of RMB10 million ($1.47 million) in a case involving the use of the shoemaker’s slanting logo.
30 August 2017 by
The implementing rules and regulations for The Philippines’s Data Privacy Act (DPA) came into force almost a year ago. However, businesses are still feeling the effects of the new law as they grapple with the requirements to seek consent from the individuals and organisations whose data they want to collect.
18 August 2017 by
President Trump has authorised an inquiry into China’s alleged theft of the intellectual property of US companies. While some believe this to be Trump’s way of forcing China to increase pressure against North Korea to stop developing nuclear weapons, others think Trump’s concern about how IP theft is affecting US businesses is genuine.
09 August 2017 by
Asialaw Leading Lawyers 2017 is now live on this website.
08 August 2017 by
Latest moves and updates from Hong Kong, India and Singapore
02 August 2017 by
From the Taj Mahal Palace Hotel to the Nokia ringtone and the stripes of 7-Eleven convenience stores, Karry Lai explains why non-traditional trade mark innovation in Asia is more than meets the eye
31 July 2017 by
Jaclyn Jhin, managing director and chief legal and compliance officer, CLSA, tells Asialaw about what it takes to be a successful in-house counsel, and the value of mentoring.
28 July 2017 by
Policymakers, academics and lawyers at a conference in Hong Kong last month spoke of the “immense opportunities” for investors in Asia in sectors such as transport and energy generation under the One Belt One Road (OBOR) initiative. They warned, however, that investors in the 65 countries along the route of OBOR must be aware of the risks in putting their money into emerging economies that may not be equipped with robust legal frameworks.
27 July 2017 by
The China Food and Drug Administration (CFDA) is planning to introduce a patent linkage scheme that will require a generic applicant to make a non-infringement declaration against an innovator’s patent portfolio. By creating this linkage, innovators can rest assured that their innovations are protected while generic drug companies are motivated to get regulatory approval for entry into market by proving that a patent is invalid or not infringed. However, observers warn of potential challenges in implementation.
26 July 2017 by
This year marks the fifth year of President Xi’s anti-corruption campaign, but China is moving only slowly up the ranks of the least corrupt jurisdictions globally. Transparency International had it at 79 on its corruption perception index in 2016, compared to 83 the year before. At the same time, proposals to amend the anti-unfair competition law, a social credit system and a national supervisory commission that is expected be in place by March 2018 shows a clear message from the Chinese government: Big Brother is watching and investigations into suspected corruption will only intensify, so businesses operating in China should ready themselves for legal consequences if their anti-corruption policies are weak.
